Genetic variations associated with the development of MASLD and MASH, such as PNPLA3, TM6SF2, GCKR, MBOAT7, MERTK, and HSD17B13, were initially reviewed. This evidence concerns the gene MBOAT7 and metabolic dysfunction-associated steatohepatitis.